Latest News

Neuron loss in schizophrenia and depression could be prevented, study suggests

Gamma-aminobutyric acid (GABA) deficits have been implicated in schizophrenia and depression. In schizophrenia, deficits have been particularly well-described for a subtype of GABA neuron, the parvalbumin fast-spiking interneurons. The activity of these neurons is critical for proper cognitive and emotional functioning. It now appears that parvalbumin neurons are particularly vulnerable to oxidative stress, a factor that may emerge commonly in development, particularly in the context of psychiatric disorders like schizophrenia or bipolar disorder, where compromised mitochondrial function plays a role.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Report recommends insurers use prescription monitoring data to reduce opioid abuse, deaths

  • Almost one-third of Canadian adults have experienced child abuse

  • Coming up with explanations helps children develop cause-and-effect thinking skills

  • Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches

  • Stroke treatment, outcomes improve with new initiative

  • Newly-approved brain stimulator offers hope for individuals with uncontrolled epilepsy

  • Cyber buddy is better than 'no buddy'

  • Innovation improves drowsy driver detection

  • Multiple sclerosis: Review of current treatments for physicians

  • Researchers compare hip width and sexual behavior

  •